Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story PBMs seek removal of ‘biased’ FTC chair, ...

Analysts upgraded shares of the healthcare company to Overweight from Equal Weight and raised their price target to $82.

Barclays upgraded CVS Health (NYSE:CVS) to Overweight from Equal Weight on Thursday, citing a compelling path to margin ...

CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.

The U.S. government on Thursday announced quality ratings for 2025 Medicare health and prescription drug plans, the first ...

On the heels of its recent announcement that CVS Health will eliminate about 2,900 jobs nationwide, the health care giant is ...

A federal antitrust watchdog is already conducting an investigation into and has filed a lawsuit against huge pharmacy ...

Barclays upgraded CVS Health Corp (NYSE: CVS) shares to Overweight from Equal Weight, citing a promising outlook for the ...

A year after emerging from bankruptcy proceedings under new ownership, Revlon has appointed a chief executive officer. Michelle Peluso, who most recently worked as the chief customer and experience ...

UnitedHealth, CVS Health, and Cigna have petitioned a judge to sideline FTC Chair Lina Khan from the agency’s lawsuit against ...

A federal antitrust watchdog is conducting an investigation into, and has filed suit against, huge pharmacy middlemen. Two ...

CVS Health, one of the biggest players in the battle to acquire physicians, is facing a possible split amid major financial struggles. In 2023, CVS Health spent $10.6 billion to acquire primary care ...